Approaching the 12th consecutive year, the goal for BioTrinity is simple – to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape the healthcare future.
BioTrinity offers unique access to investors, big pharma executives and innovative CEO's of emerging R&D companies seeking to strike deals and grow their networks.
BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors. For more information on OBN visit the website.
Novotel London West